. . . . . . . . "Some reduction in transactivation but, completely abolishes MAPK9-mediated activation. Abolishes MAPK9-mediated and greatly reduces adenovirus E1A-mediated transactivation; when associated with A-51 and A-53. Abolishes adenovirus 2 E1A-mediated transactivation; when associated with A-14; A-51 and A-53." . "112"^^ . . "112"^^ . . "Mutagenesis site occurs in NX_P17544-3 at amino acids 112 - 112." . . . . . "neXtProt gold" . . . . . . . . . "2014-09-19T00:00:00.0Z"^^ . . . "neXtProt database" . "CALIPHO project" . . . . . "2" . . .